Рет қаралды 1,248
During the 2022 ASCO Annual Meeting, the Lymphoma Hub spoke with Alison Moskowitz, Feinstein Institutes for Medical Research, New York, US. We asked, What are the latest treatment advances for Hodgkin lymphoma?
Moskowitz begins by discussing the evolution of treatment for Hodgkin lymphoma and the impact positron emission tomography (PET)-adapted therapy has had in the field. Moskowitz outlines recent studies and new therapies that are significantly changing the treatment landscape.